Inspiration Point-A Digital Pulmonary Rehabilitation Tool Management Interventions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03801330|
Recruitment Status : Recruiting
First Posted : January 11, 2019
Last Update Posted : August 20, 2021
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|COPD||Other: Usual Care Pulmonary Rehabilitation Program Other: Pulmonary Rehabilitation Software-Based Home Program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||36 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Inspiration Point-A Digital Pulmonary Rehabilitation Tool for Use With Self- Management Interventions|
|Actual Study Start Date :||November 1, 2020|
|Estimated Primary Completion Date :||February 1, 2022|
|Estimated Study Completion Date :||February 1, 2022|
Active Comparator: Usual Care
Participants in the Usual Care Pulmonary Rehabilitation will receive usual care pulmonary rehab program. Usual care programs typically consist of exercises including upper extremity strengthening, lower extremity strengthening, aerobic exercises such as walking and balance training. Each program is personalized as per the participant's ability. The intervention is usual care exercise and education, which is personalized for each participant. No drugs are being tested in this study.
Other: Usual Care Pulmonary Rehabilitation Program
Participants in the Usual Care Pulmonary Rehabilitation Program group will complete an 8 week clinic based Pulmonary Rehabilitation Program (usual care).
Experimental: Software Tool
Participants in the Pulmonary Rehabilitation Software-Based Home Program will use a digital software tool (APP) to obtain the pulmonary rehab home program. Home programs typically consist of exercises including upper extremity strengthening, lower extremity strengthening, aerobic exercises such as walking and balance training. Each program is personalized as per the participant's ability. The intervention is exercise and education, which is personalized for each participant. No drugs are being tested in this study.
Other: Pulmonary Rehabilitation Software-Based Home Program
Participants in the Pulmonary Rehabilitation Software-Based Home Program group will complete an 8-week home-based Pulmonary Rehabilitation Program using a software app (software)
- 6 Minute Walk Test [ Time Frame: Change from baseline 6 Minute Walk Test score at 2 months ]Measures distance walked in 6 minutes
- Modified Medical Research Council Dyspnea Scale (mMRC) [ Time Frame: Change from baseline Modified Medical Research Council Dyspnea Scale (mMRC) score at 2 months ]Single question questionnaire describing shortness of breath. Total Score Range from 0-4, 0 is better.
- Medical Outcomes Scale VR-12 [ Time Frame: Change from baseline VR-12 score at 2 months ]
Survey of health status and quality of life
From (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) "Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per the scoring key given in Table 1. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Table 2 lists the items averaged together to create each scale. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered."
- St Georges Respiratory Questionnaire (SGRQ) [ Time Frame: Change from baseline St Georges Questionnaire score at 2 months ]
A self-administered disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. The questionnaire has 50 items Scores range from 0-100, with higher scores indicating more limitations
- Lung Information Needs Questionnaire (LINQ) [ Time Frame: Change from baseline Lung Information Needs Questionnaire score at 2 months ]
The questionnaire used to identify a person with COPD's need for information about their disease. The questionnaire measures the extent to which the patient needs more information, as perceived by the patient and clinician. It is scored to produce an overall score and 6 domain scores (Disease knowledge, medicines, self-management, exercise, diet, smoking).
The score is the sum of all 6 domains with a range from 0-25. High scores indicate high information needs, a lower score is better.
- Software Usability Scale (SUS) [ Time Frame: Change from baseline Software Usability Scale (SUS)score at 2 months ]Measures usability and learnability of software tools. Total Score provides percentile score indicating usability/learnability. Range 0-100, Higher (100%) is better.
- Timed Up and Go Test (TUG) [ Time Frame: Change from baseline TUG score at 2 months ]Measures the time taken to stand up from a chair, walk 10 feet, turn around, and return to sitting.
- 30 Second Sit to Stand Test (30STST) [ Time Frame: Change from baseline 30STST score at 2 months ]Measures the number of times a participant can stand from a seated position in 30 seconds
- 4 Stage Balance Test (4SBT) [ Time Frame: Change in 4STBT score at 2 months ]Measures balance in 4 increasing more challenging positions
- COPD Assessment Test (CAT) [ Time Frame: Change in CAT score at 2 months ]An 8 item test which measures the effect of COPD on a patient's overall health. The items on this test measure a patient's cough, sputum, breathlessness, chest tightness, confidence, activity, sleep and energy levels
- Depression Screen (DS) [ Time Frame: Change in DS score at 2 months ]A 2 question survey which can be used to evaluate your risk of depression
- Charlson Index (CCI) [ Time Frame: Change in CCI score at 2 months ]The Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions, such as heart disease or cancer (a total of 22 conditions). This index is helpful to ensure the groups are equal for the study comparison and statistics.
- Fall Risk Questionnaire (FRQ) [ Time Frame: Change in FRQ score at 2 months ]The FRQ is comprised of 13 questions about a person's history of falls and potential fall risk.
- Positive Affect and Well-Being Short Form (PROMIS) [ Time Frame: Change in PROMIS score at 2 months ]This test is a health-related quality of life questionnaire.
- Single Item Literacy Screener (SILS) [ Time Frame: Change in SILS score at 2 months ]The SILS is a single item survey which determines literacy and health literacy. It is a direct assessment of a patient's need for assistance in reading health materials.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Participants will have physician permission and diagnosis COPD (FEV1 >30%-80%),
- Gold level A-D, and
- Ability to perform the 6 Minute Walk Test (6MWT).
- This means that participants must meet the standard definition of COPD and have a post-bronchodilator measurement of FEV1/FVC < 0.7.
- All COPD Assessment Test scores will be accepted.
- Patients must have an mMRC score = 1-4.
- Additionally, patients must have taken a Pulmonary Function Test within 1 year or they must retake (for baseline measurement) before participating in the study.
- Patients must not have had a Pulmonary Rehabilitation class within the last 6 months.
- If participants have had a recent cardiac event within 6 months (such as a myocardial infarction or an abnormal cardiac catheterization) they must obtain cardiologist approval before participating in the study.
- In an effort to evaluate feasibility we will request that participants have their own Wi-Fi. Participants may use their own mobile device if they prefer but Blue Marble will have ample supply to provide to participants a device for the purposes of this study.
- Target representativeness for gender, based on COPD demography will be ~50% women, based on recent trends indicating that women have an equal, and perhaps slightly greater risk of COPD compared to men3.
- The Ethnicity/Race target recruitment, consistent with the US and the population at each site.
- Participants must speak, read, and understand English at or above the 6th-grade level (as indicated by having a driver's license or self-report of completion of some high school).
Exclusion Criteria for participants with COPD:
- Pulmonary functional fitness that precludes participation in outpatient/home PR program (i.e. requires in-patient supervision or severity of a co-morbidity that represents a contradiction to exercise in a self-directed program) will be exclusionary.
- A participant who desaturates below SaO2 <88% during the pre-test 6MWT and does not have personal oxygen available will be referred for further evaluation and can be included once they have an O2 titration and supplemental oxygen.
- Other exclusions include if a patient's oxygen use exceeds 4 liters per minute (LPM) or those who score less than 100 meters during the entry 6-minute walk distance.
- Participants with coronary problems will be excluded based on specific morbidity and severity. These coronary exclusions include coronary artery disease with unstable angina.
- Additional exclusions include: any respiratory disorder other than COPD that contraindicates participation in a home-based program.
- The inability to learn how to use Inspiration Point
- An acute neurological or cardiovascular condition such as stroke or acute heart surgery.
- Active cancer with an anticipated survival of less than 6 months or treatment that will preclude them from participating in Pulmonary Rehab.
- A participant with high fall risk as per physician determination.
- The presence of a neurologic disorder that precludes a potential participant from following a typical COPD exercise program or demonstrating hand function sufficient to interface with the tablet.
- This also includes patients with prior or current neurologic event/condition presenting fall risk or requiring assist device for ambulation will also be excluded.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03801330
|Contact: Sheryl M Flynn, PT PhDfirstname.lastname@example.org|
|Contact: William Pu, MS-GHemail@example.com|
|United States, North Carolina|
|Wake Forest Baptist Health||Recruiting|
|Charlotte, North Carolina, United States, 28203|
|Contact: Jill Ohar, MD 336-713-8850 firstname.lastname@example.org|
|Contact: Sharon Cornelison 336-713-8850 email@example.com|
|United States, West Virginia|
|Cabin Creek Health Systems Inc||Recruiting|
|Dawes, West Virginia, United States, 25054|
|Contact: Daniel Doyle, MD 304-595-5006 firstname.lastname@example.org|
|Contact: Krista Clark, CRT 3045955006 email@example.com|
|New River Health Association||Recruiting|
|Scarbro, West Virginia, United States, 25917|
|Contact: Daniel Doyle, MD 304-573-1798 firstname.lastname@example.org|
|Contact: Carrie Cashen, RRT 3044692905 ext 1316 email@example.com|
|Principal Investigator:||Sheryl Flynn, PT PhD||Blue Marble Health|
|Responsible Party:||Blue Marble Rehab Inc|
|Other Study ID Numbers:||
|First Posted:||January 11, 2019 Key Record Dates|
|Last Update Posted:||August 20, 2021|
|Last Verified:||August 2021|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Plan Description:||To be determined|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Respiratory Tract Diseases